AERA DEVRIES: Open Payments
NPI 1124870027 · ZEELAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 31 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $976
Food & beverage: $916Education: $60
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $286 |
| AstraZeneca Pharmaceuticals LP | 7 | $227 |
| Novo Nordisk Inc | 6 | $214 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| PFIZER INC. | 2 | $43 |
| Amgen Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| ABBVIE INC. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $17 |
Products named: Veozah, AIRSUPRA, Ozempic, Wegovy, TRELEGY ELLIPTA, PREVNAR 20, Kerendia, VAXNEUVANCE.
Industry payments across MI — which companies pay providers there.
